Table 2.
Parameter | AS patients (n = 48) | Healthy subjects (n = 48) | p |
---|---|---|---|
SOD (p) (NU/ml) | 12.67 ± 1.98 | 10.93 ± 2.55 | <0.001 |
SOD-Mn (p) (NU/ml) | 5.08 ± 2.00 | 4.59 ± 1.88 | 0.223 |
SOD-CuZn (p) (NU/ml) | 7.64 ± 2.31 | 6.79 ± 1.99 | 0.055 |
SOD (e) (NU/mgHb) | 105.85 ± 22.60 | 95.50 ± 19.18 | 0.017 |
CAT (e) (IU/mgHb) | 410.98 ± 63.56 | 352.55 ± 77.21 | <0.001 |
GPx (e) (IU/gHb) | 27.23 ± 6.43 | 24.49 ± 5.00 | 0.022 |
GR (e) (IU/gHb) | 1.67 ± 0.58 | 1.38 ± 0.43 | 0.007 |
FRAP (p) (μmol/l) | 550.38 ± 76.98 | 642.17 ± 105.67 | <0.001 |
PSH (s) (μmol/l) | 474.46 ± 192.06 | 559.07 ± 215.14 | 0.045 |
UA (s) (mg/dl) | 4.73 ± 1.39 | 5.84 ± 1.53 | <0.001 |
Values are expressed as means ± standard deviations (SD) of the means; p: plasma; s: serum; e: erythrocyte lysates.